Tango Therapeutics, Inc. · NASDAQ:TNGX
Rothenberg Mace received 4,000 Tango Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Rothenberg Mace (Director) received 4,000 Tango Therapeutics, Inc. shares as an award, leaving 41,500 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 4,000 shares
- Holding after
- 41,500 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 4,000 | 41,500 | Direct |